InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Braveheart Bio, Inc.

BRVE
United States Fiscal year ends December CIK 0002131524
20.02
+4.87%
Close, 9 Oct 2026 · USD
Alert on the numbers Alert on insider trades

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
20.02 on 9 Oct 2026
30 24 19 Aug 2026 Sep 2026 Oct 2026 6 Aug 2026 $29.80 7 Aug 2026 $30.00 10 Aug 2026 $27.53 11 Aug 2026 $25.01 12 Aug 2026 $26.15 13 Aug 2026 $25.97 14 Aug 2026 $27.03 17 Aug 2026 $27.66 18 Aug 2026 $26.75 19 Aug 2026 $28.97 20 Aug 2026 $27.42 21 Aug 2026 $27.58 24 Aug 2026 $27.50 25 Aug 2026 $27.64 26 Aug 2026 $27.76 27 Aug 2026 $27.86 28 Aug 2026 $27.44 31 Aug 2026 $25.50 1 Sep 2026 $26.28 2 Sep 2026 $26.95 3 Sep 2026 $26.27 4 Sep 2026 $26.74 8 Sep 2026 $29.41 9 Sep 2026 $28.91 10 Sep 2026 $27.25 11 Sep 2026 $26.64 14 Sep 2026 $27.02 15 Sep 2026 $26.71 16 Sep 2026 $27.45 17 Sep 2026 $27.71 18 Sep 2026 $29.20 21 Sep 2026 $25.02 22 Sep 2026 $23.61 23 Sep 2026 $21.46 24 Sep 2026 $23.37 25 Sep 2026 $20.62 28 Sep 2026 $21.07 29 Sep 2026 $22.34 30 Sep 2026 $20.20 1 Oct 2026 $21.41 2 Oct 2026 $21.27 5 Oct 2026 $21.35 6 Oct 2026 $19.79 7 Oct 2026 $18.58 8 Oct 2026 $19.09 9 Oct 2026 $20.02 Anderson Michele A. Chief Development Officer Bought $20.00K 7 Aug 2026 · at $18.00 · 0.3% of stake Malek David I Director Bought $74.99K 7 Aug 2026 · at $18.00 · 0.8% of stake Rickey James Paul Chief Financial Officer Bought $499.99K 7 Aug 2026 · at $18.00 · 5.6% of stake Lubner David Charles Director Bought $999.99K 7 Aug 2026 · at $18.00 Murdoch Travis CEO and President Bought $1.50M 7 Aug 2026 · at $18.00 · 2.9% of stake Viehbacher Christopher Director Bought $1.50M 7 Aug 2026 · at $18.00 · 15.8% of stake AH Bio Fund IV, L.P. 10% owner Bought $19.80M 7 Aug 2026 · at $18.00 · 12.0% of stake Forbion Growth Opportunities … 10% owner Bought $30.24M 7 Aug 2026 · at $18.00 · 19.8% of stake Forbion Growth Opportunities … 10% owner Bought $34.56M 7 Aug 2026 · at $18.00 · 19.8% of stake ORBIMED ADVISORS LLC Director Bought $34.92M 7 Aug 2026 · at $18.00 · 19.5% of stake Chimovits Erez Director Bought $34.92M 7 Aug 2026 · at $18.00 · 19.5% of stake
11 buys0 sales at will0 planned sales

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
7 Aug 2026 Chimovits Erez
Director
 Bought $34.92M 19.5%
7 Aug 2026 ORBIMED ADVISORS LLC
Director
 Bought $34.92M 19.5%
7 Aug 2026 Forbion Growth Opportunities Fund III Cooperatief U.A.
10% owner
 Bought $34.56M 19.8%
7 Aug 2026 Forbion Growth Opportunities Fund III Cooperatief U.A.
10% owner
 Bought $30.24M 19.8%
7 Aug 2026 AH Bio Fund IV, L.P.
10% owner
 Bought $19.80M 12.0%
7 Aug 2026 Viehbacher Christopher
Director
 Bought $1.50M 15.8%